21世纪经济报道记者韩利明 生物医药企业赴港上市热潮持续涌动。据港交所官网信息显示,自9月15日至今近一个月时间内,已有安徽华恒生物、贝达药业、长春高新、诚益生物、滨会生物、先为达生物、麦科奥特医药等超12家药企递交IPO申请,业务范围涵盖创新药物研发、疫苗等多个领域。 在赴港上市队伍中,今年6月已完成递表的轩竹生物率先迎来新进展。10月15日,该公司以29.46港元/股开盘,较11.6港元/...
Source Link21世纪经济报道记者韩利明 生物医药企业赴港上市热潮持续涌动。据港交所官网信息显示,自9月15日至今近一个月时间内,已有安徽华恒生物、贝达药业、长春高新、诚益生物、滨会生物、先为达生物、麦科奥特医药等超12家药企递交IPO申请,业务范围涵盖创新药物研发、疫苗等多个领域。 在赴港上市队伍中,今年6月已完成递表的轩竹生物率先迎来新进展。10月15日,该公司以29.46港元/股开盘,较11.6港元/...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.